Allergan's tribal licensing deal, opposed by tech giants, gets appeals court scrutiny

Allergan attracted a wide range of opposition with its Saint Regis Mohawk Tribe licensing deal last year, and now, the unique patent strategy is under the lens at the U.S. Court of Appeals for the Federal Circuit.